LGVN4:05 PMLongeveron Announces 2026 Second Quarter Financial Results and Provides Business Updatelongeveron.com
LGVN9:05 AMLongeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competitionlongeveron.com
LGVN4:05 PMLongeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026longeveron.com
LGVN7:05 AMLongeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s DiseasePresentation / Abstractlongeveron.com